Inter-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Insulin-Treated Type 2 Diabetes Patients on Hemodialysis

Glucose Monitoring ◽

Glycemic Variability ◽

The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial

Diabetes Technology & Therapeutics ◽

10.1089/dia.2017.0028 ◽

2017 ◽

Vol 19 (8) ◽

pp. 457-462 ◽

Cited By ~ 8

Author(s):

Hiroyuki Iuchi ◽

Masaya Sakamoto ◽

Daisuke Matsutani ◽

Hirofumi Suzuki ◽

Ryuzo Horiuchi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Crossover Trial ◽

Glucose Monitoring ◽

Glycemic Variability ◽

Randomized Crossover Trial ◽

Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring

Diabetes Technology & Therapeutics ◽

10.1089/dia.2017.0306 ◽

2018 ◽

Vol 20 (2) ◽

pp. 140-146 ◽

Cited By ~ 9

Author(s):

Fumi Uemura ◽

Yosuke Okada ◽

Keiichi Torimoto ◽

Yoshiya Tanaka

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Glucose Monitoring ◽

Glycemic Variability ◽

924-P: Pattern Mining of Trajectories of Glucose Values of Continuous Glucose Monitoring System by Artificial Intelligence in Type 2 Diabetes Patients

Diabetes ◽

10.2337/db19-924-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 924-P

Author(s):

MASAKI MAKINO ◽

RYO YOSHIMOTO ◽

MIZUHO KONDO-ANDO ◽

YASUMASA YOSHINO ◽

IZUMI HIRATSUKA ◽

...

Keyword(s):

Artificial Intelligence ◽

Type 2 Diabetes ◽

Monitoring System ◽

Pattern Mining ◽

Glucose Monitoring ◽

Continuous Glucose Monitoring System ◽

Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)

Diabetes Therapy ◽

10.1007/s13300-017-0274-3 ◽

2017 ◽

Vol 8 (4) ◽

pp. 821-827 ◽

Cited By ~ 18

Author(s):

Mihoko Matsumura ◽

Yuki Nakatani ◽

Seiichi Tanka ◽

Chie Aoki ◽

Masaaki Sagara ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Glucose Monitoring ◽

Use of continuous glucose monitoring for control assessment in type 2 diabetes patients

Endocrine Abstracts ◽

10.1530/endoabs.73.aep230 ◽

2021 ◽

Author(s):

Tzvetelina Totomirova ◽

Mila Arnaudova ◽

Maria Lazova

Keyword(s):

Type 2 Diabetes ◽

Glucose Monitoring ◽

Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes

Pediatric Diabetes ◽

10.1111/pedi.12475 ◽

2016 ◽

Vol 18 (7) ◽

pp. 629-636 ◽

Cited By ~ 10

Author(s):

Christine L. Chan ◽

Laura Pyle ◽

Megan M. Kelsey ◽

Lindsey Newnes ◽

Amy Baumgartner ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glucose Monitoring ◽

Glycemic Variability ◽

Glycemic Markers

Decision letter for "Improved Glycemic Variability and Time in Range with Dapagliflozin versus Gliclazide Modified Release among Adults with Type 2 Diabetes Evaluated by Continuous Glucose Monitoring: A 12‐week Randomized Controlled Trial"

10.1111/dom.13913/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Glucose Monitoring ◽

Glycemic Variability ◽

Modified Release ◽

Randomized Controlled ◽

Review for "Improved Glycemic Variability and Time in Range with Dapagliflozin versus Gliclazide Modified Release among Adults with Type 2 Diabetes Evaluated by Continuous Glucose Monitoring: A 12‐week Randomized Controlled Trial"

10.1111/dom.13913/v2/review3 ◽

2019 ◽

Author(s):

Tasuku Terada

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Glucose Monitoring ◽

Glycemic Variability ◽

Modified Release ◽

Randomized Controlled ◽

Review for "Improved Glycemic Variability and Time in Range with Dapagliflozin versus Gliclazide Modified Release among Adults with Type 2 Diabetes Evaluated by Continuous Glucose Monitoring: A 12‐week Randomized Controlled Trial"

10.1111/dom.13913/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Glucose Monitoring ◽

Glycemic Variability ◽

Modified Release ◽

Randomized Controlled ◽

Review for "Improved Glycemic Variability and Time in Range with Dapagliflozin versus Gliclazide Modified Release among Adults with Type 2 Diabetes Evaluated by Continuous Glucose Monitoring: A 12‐week Randomized Controlled Trial"

10.1111/dom.13913/v1/review3 ◽

2019 ◽

Author(s):

Tasuku Terada

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Glucose Monitoring ◽

Glycemic Variability ◽

Modified Release ◽

Randomized Controlled ◽